Sales 2024 * | 101M 138M | Sales 2025 * | 113M 154M | Capitalization | 183M 250M |
---|---|---|---|---|---|
Net income 2024 * | -13M -17.78M | Net income 2025 * | -10M -13.68M | EV / Sales 2024 * | 1.81 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
-13.4
x | P/E ratio 2025 * |
-17.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.3% |
Latest transcript on OptimizeRx Corporation
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | 01-23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
1st Jan change | Capi. | |
---|---|---|
+26.84% | 439B | |
+38.61% | 291B | |
+18.04% | 152B | |
+11.38% | 96.26B | |
+23.25% | 87.42B | |
+66.99% | 62.46B | |
+10.00% | 44.48B | |
+14.04% | 34.15B | |
-15.16% | 30.29B |